As Vice President and Chief Innovation Officer, Dr. Eskandanian leads the strategic and operation management of novel product development at Children’s National, with a focus on translating pediatric innovation to patients and families. She is the Managing Director of Innovation Ventures, the commercialization arm of Children’s National, the Executive Director of the Sheikh Zayed Institute for Pediatric Surgical Innovation, Principal Investigator of the Alliance for Pediatric Device Innovation, an FDA-funded initiative, and Principal Investigator of SPARK (Special Populations Accelerator for Research and Knowledge) for Innovations in Pediatrics, an ASPR/BARDA initiative. Dr. Eskandanian works with a large network of small and large businesses, nonprofits, and government agencies to maximize the commercial potential of pediatric novel products. Since early 2014, over 400 pediatric medical device companies have been funded or received technical expertise through initiatives led by Dr. Eskandanian. Her own innovations are in the market space used by millions. Dr. Eskandanian is the lead inventor of the first-ever adverse event reporting system, initially deployed in a research academic environment. She has had leadership roles in the development of the first web-based consumer trouble-entry management system for a Fortune 100 company in the telecommunications sector. In her role in academia, she has been instrumental in securing over $100 million in peer-reviewed government funding. Prior to joining Children’s National, Dr. Eskandanian held positions with Intelsat, Accenture, and Georgetown University. Dr. Eskandanian’s background is in mechanical engineering with a PhD in operations science and an MBA.